?glioblastoma

glioblastoma發(fā)音

英：[?gl???bl?'st??m?]　　美：[?gl?o?bl?'sto?m?]

英：　　美：

glioblastoma中文意思翻譯

n. 膠質(zhì)母細胞瘤 惡性膠質(zhì)瘤；成膠質(zhì)細胞瘤

glioblastoma常見(jiàn)例句

1 、Objective This study aims to screen the differentially expressed genes of glioblastoma using microarray technology.───目的用生物芯片篩選膠質(zhì)母細胞瘤相關(guān)基因。

2 、Clinical study on progrostic scale for patients with glioblastoma multiforme───多形性膠質(zhì)母細胞瘤預后分級研究

3 、Glioblastoma multiform (GBM) is the most common type of primary brain tumor according for more than 40% of neoplasm in the central nervous system.───神經(jīng)膠質(zhì)瘤是主要的原發(fā)性腦部腫瘤，占到了中樞神經(jīng)系統腫瘤的40%。

4 、It's called a glioblastoma it's one of the fastest moving brain cancers.─── 那是惡性膠質(zhì)瘤 是轉移最快的腦腫瘤之一

5 、Glioblastoma (GBM) only rarely occurs congenitally and has not been fully characterized.───很少有先天性的惡性膠質(zhì)瘤（GBM），它還沒(méi)有被充分地研究。

6 、Objective Tor improve the recognization of some special morphological types of glioblastoma.───目的提高對膠質(zhì)母細胞瘤的某些特殊形態(tài)類(lèi)型的認識。

7 、Objective: To explore MRI features of peritumoral infarction following resection of glioblastoma multiforme (GBM) and evaluate their clinical significance.───摘要目的：探討膠質(zhì)母細胞瘤術(shù)后瘤周梗塞的MRI特征，并評價(jià)其臨床意義。

8 、I would carefully review the MRI and vigorously rule out glioblastoma first.───我會(huì )查看患者M(jìn)RI情況，首先排除膠質(zhì)母細胞瘤。

9 、Objective To evaluate the main treatment methods and safety for long-time survival patients of glioblastoma.───目的探討腦惡性膠質(zhì)瘤長(cháng)期生存患者的主要治療方法和安全性。

10 、Only 3 percent of people with glioblastoma surie fie years, with the aerage surial being just under a year.───只有百分之三患了膠質(zhì)母細胞瘤的病人能存活五年以上，平均存活期只有不到一年。

11 、An allelotype study of primary and corresponding recurrent glioblastoma multiforme───復發(fā)前后多形性膠質(zhì)母細胞瘤的等位基因譜分析

12 、MRI images often show a ring-enhancing lesion surrounded by edema, a picture indistinguishable from glioblastoma, abscess, and other tumors (including metastasis).───MRI圖像顯示一環(huán)形水腫**損，常難以與惡性膠質(zhì)瘤、潰瘍以及其它腫瘤（包括轉移灶）相鑒別。

13 、Proliferation and radiosensitivity in human primary culture glioblastoma multiforme───原代培養多形性膠質(zhì)母細胞瘤的增殖與放射敏感性

14 、Expression absence of LRRC4 gene in glioblastoma cell lines───LRRC4基因在腦膠質(zhì)瘤細胞系中表達缺失

15 、We review recent data that stem cells of glioblastoma, a highly malignant brain tumour, seem to be dependent on cues from aberrant vascular niches that mimic the normal neural stem cell niche.───我們回顧了惡性膠質(zhì)瘤干細胞的最新數據，其似乎依賴(lài)于模仿正常神經(jīng)干細胞微環(huán)境的異常所提供的線(xiàn)索。這些數據對該腫瘤有著(zhù)直接的意義。

16 、Giant cell glioblastoma───巨細胞成神經(jīng)膠質(zhì)細胞瘤

17 、Aim:To study the dynamic expression of green fluorescent protein (GFP) and enhanced green fluorescent protein (EGFP) on C6 glioblastoma cells in vivo.───目的:研究綠色熒光蛋白報道基因體外轉染C6膠質(zhì)瘤細胞系的動(dòng)態(tài)表達。

18 、The influences of VM-26 on proliferation in human glioblastoma multiforme BT-325───VM-26對人多形性膠質(zhì)母細胞瘤BT-325細胞增殖的影響

19 、Previous research had analyzed the protein and lipid content of glioblastoma microvesicles.───前期的研究分析了腦腫瘤微泡的蛋白質(zhì)成分和脂肪成分。

20 、Establishment of a human glioblastoma multiforme cell line "BT_(325)───人腦多形性膠質(zhì)母細胞瘤細胞系“BT325”的建立及其生物學(xué)特性

21 、They then began an experiment on 21 patients who had been diagnosed with glioblastoma.───接著(zhù)，他們開(kāi)始在21名此前被診斷患有成膠質(zhì)細胞瘤的病人身上進(jìn)行一項實(shí)驗。

22 、His team studied 20 different batches of glioblastoma cells in the lab and found that many growth switches were flipped on at once.───他的團隊研究了實(shí)驗室里的20批不同的膠質(zhì)母細胞瘤細胞，發(fā)現很多生長(cháng)調控點(diǎn)瞬間會(huì )變化。

23 、Leading the list were reports on pancreatic cancer and glioblastoma, the deadliest cancers.───排在成果首位的是胰腺癌和膠質(zhì)母細胞瘤、兩種最致命的癌癥。

24 、Apoptosis of glioblastoma multiforme cells induced by VM-26 treatment in vitro───VM-26誘導膠質(zhì)母細胞凋亡的實(shí)驗研究

25 、It appears as if the treatment you were receiving in the clinical trial has slowed the growth of the glioblastoma.─── 看來(lái)你在臨床試驗中 接受的治療 減緩了惡性膠質(zhì)瘤的增長(cháng)

26 、He designed it so that you'd manifest the symptoms of a glioblastoma.─── 他設計的藥物 讓你產(chǎn)生 惡性膠質(zhì)瘤的癥狀

27 、Both are symptoms of glioblastoma, a highly aggressive brain tumor.─── 兩者都是惡性膠質(zhì)瘤的癥狀 是種致死率極高的腦部腫瘤

28 、Methods:VEGF antisense eDNA was transfected into C6 glioblastoma cells mediated with Lipofectamine. The inhibitory of VEGF antisense RNA on the proliferation and apoptosis of C6 cells in vitro were obserced.───方法用Lipofectamine介導的方法將VEGF反義eDNA轉染入C6鼠膠質(zhì)瘤細胞系,觀(guān)察其對細胞增殖和凋亡的影響。

29 、primary glioblastoma───原發(fā)膠質(zhì)母細胞瘤

30 、Stratmann A, Risau W, Plate K H. Cell typespecific expression of angiopoietin1 and angiopoietin2 suggests a role in Glioblastoma angiogenesis. Am J Pathol,1998,14591466.───王鈞,吳開(kāi)春,張德新等.人血管生成素1基因轉染對胃癌細胞體內致瘤力及血管生成的影響.中華腫瘤雜志,2005,27:7780.

31 、They discovered cytomegalovirus in the tumours of more than 90% of those people with glioblastoma whom they examined, but not in healthy brain tissue, nor in non-m alignant brain tumours.───他們在所檢查過(guò)的90%以上患成膠質(zhì)細胞瘤的病人的腫瘤內發(fā)現了巨細胞病毒，而在健康的腦組織和良性腦瘤中均沒(méi)發(fā)現。

32 、Kill Effect of Herpes Simplex Virus Thymidine Kinase Gene on Human Multiform Glioblastoma Cells───單純皰疹病毒胸苷激酶基因對人膠質(zhì)母細胞瘤細胞的殺傷效應研究

33 、Keywords loss of heterozygosity（LOH） glioblastoma tumor suppressor genes;───關(guān)鍵詞雜合性缺失;膠質(zhì)母細胞瘤;腫瘤抑制基因;

34 、Wrann M，Thomas L，Larry K，et al.T cell suppressor factor from human glioblastoma cells is a 12.5 kd protein related to transforming growth factor.The EMBO Joural，1987，6：1633.───林彤，浦佩玉，鐘述猷。神經(jīng)膠質(zhì)瘤患者細胞免疫功能變化及其降低機制.中國免疫學(xué)雜志，1991，4：238.

35 、Glioblastoma multiform is one of the most common types of primary central nervous system tumors with dismal prognosis.───摘要多形性腦膠質(zhì)母細胞瘤是最常見(jiàn)的顱內腫瘤之一且預后差。

36 、glioblastoma multiforme───多形性成膠質(zhì)細胞瘤

37 、Andropov he he designed it so that you'd manifest the symptoms of a glioblastoma.─── 安德羅波夫...他... 他設計的藥物 讓你產(chǎn)生 惡性膠質(zhì)瘤的癥狀

38 、The normal prognosis for glioblastoma is death within two years, even if a patient is treated with chemotherapy and radiation.───對成膠質(zhì)細胞瘤，一般預測病人在兩年內死亡，即使他接受化療和放療。

39 、Expression and Significance of Urokinase - type Plasminogen Activator in Glioblastoma───尿激酶型纖溶酶原激活劑在膠質(zhì)母細胞瘤中表達及意義

40 、Invasion is a defining hallmark of glioblastoma multiforme, just as metastasis characterizes other high-grade tumors.───侵襲是多形性惡性膠質(zhì)瘤的特征之一，就如同轉移是低分化腫瘤的特征一樣。

41 、Keywords Glioblastoma;Phage li-brary;Tumor targeting;Whole cell screening;───關(guān)鍵詞神經(jīng)膠質(zhì)細胞瘤;噬菌體肽庫;腫瘤導向;全細胞篩選;

42 、Glioblastoma Multiform───多行性腦膠質(zhì)母細胞瘤

43 、Objective To explore the clinical significance and the expression of phosphorylated c-Jun N-terminal kinase (p-JNK) and phosphorylated c-Jun (p-c-Jun) in glioblastoma (GBM).───目的探討**酸化JNK(p-JNK)與**酸化c-Jun(p-c-Jun)在多形性膠質(zhì)母細胞瘤(GBM)中的表達及意義。

44 、Multiform peripheral blood lymphocyte gene expression spectrum in glioblastoma patients───惡性膠質(zhì)瘤患者外周血淋巴細胞基因表達譜的研究

45 、An allelotype study of human glioblastoma───人膠質(zhì)母細胞瘤等位基因譜分析的研究

46 、Results This case is consistent with the criteria on the glioblastoma mutiforme following cerebral trauma in literatures.───結果本病例完全符合文獻中關(guān)于腦外傷后膠質(zhì)瘤的判定標準。

47 、Nursing care of postoperative polymorph glioblastoma patients undergoing combined chemotherapy───多形性膠質(zhì)母細胞瘤術(shù)后聯(lián)合化療病人的護理

48 、The research suggests it could be very effective in cases of glioblastoma.─── 研究稱(chēng)這是 治療膠質(zhì)母細胞瘤很有效的辦法

49 、Glioblastoma with sarcomatous component───神經(jīng)膠質(zhì)母細胞瘤伴肉瘤成分

50 、STUDY OF WHOLE-MOUNT CYTOSKELETON OF HUMAN GLIOBLASTOMA BT_(325) CELLS BY CARBONPLATINUM COATING AND IMMUNOELECTRON MICROSCOPY───用碳-鉑復型與免疫電鏡技術(shù)對人腦膠質(zhì)瘤細胞系BT_(325)整裝細胞骨架的研究

51 、Nomograms based on long follow-up data from chemoradiotherapy in glioblastoma multiforme can now help to predict the prognosis of the individual patient.───基于多形性膠質(zhì)母細胞瘤化放療后的長(cháng)期隨訪(fǎng)資料的數據圖，現在可以用于預測不同患者的預后。

52 、Study on allelic imbalance of chromosome 7 in primary glioblastoma multiforme───原發(fā)性多形性膠質(zhì)母細胞瘤7號染色體等位基因失平衡狀況的研究

53 、METHODS and MATERIAL: The study population includes 22 patients with recurrent glioblastoma who underwent Thallium-201 Single Photon Emission Computerized Tomography (Tl 201 SPECT)and Magnetic Resonance Imaging (MRI).───方法：22例復發(fā)的膠質(zhì)母細胞瘤經(jīng)歷了鉈201單光子發(fā)射計算機斷層掃描（Tl201SPECT）和核磁共振成像（MRI）檢查。

54 、Keywords piezoelectric sensor;nucleic acid aptamer;self-assembly;glioblastoma cell;───壓電傳感器;核酸適體;自組裝;星形膠質(zhì)瘤細胞;

55 、Human glioblastoma cells(HGC),human embryonic pulmonary cells(HEPC),monkey kidney cells(V-116)and K562 cells were infected by T. gondii. The infective states were observed by electron microscope.───用電鏡觀(guān)察了弓形蟲(chóng)在人腦惡性膠質(zhì)瘤細胞（HGC）、人胚肺細胞（HEPC）、人K562細胞和猴腎細胞（V－116）中感染和寄生狀況及受感染細胞的病理變化。

56 、14. Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma.───對初步診斷為膠質(zhì)母細胞瘤采用劑量密集型或節拍型替莫唑胺給藥的隨機II期臨床化放療實(shí)驗。

57 、3. CONCLUSION: SEGA is a benign,slowly growing and possible multidifferentiated tumor,and it should be differentiated from giant cell glioblastoma,gemistocytic astrocytoma and ependymoma.───結論:SEGA為生長(cháng)緩慢的良性腫瘤,生存時(shí)間長(cháng),預后良好,可能具有多向分化潛能,病理確診須與巨細胞性膠質(zhì)母細胞瘤、肥胖細胞性星形細胞瘤和室管膜瘤等鑒別。收藏指正

58 、This glioblastoma multiforme (GBM) demonstrates marked cellularity with marked hyperchromatism and pleomorphism.───多形性膠質(zhì)母細胞瘤(GBM)顯示腫瘤細胞深染和多形性。

59 、Keywords loss of heterozygosity;allelotype;glioblastoma;tumor suppressor genes;───雜合性丟失;等位基因譜分析;膠質(zhì)母細胞瘤;腫瘤抑制基因;

60 、Objective:To find out the effective method of establishing rat C6 glioblastoma model ,and assess the feasibility of dynamic observasion with MRI.───目的:探索建立大鼠C6膠質(zhì)瘤模型的有效方法,了解MRI動(dòng)態(tài)檢測腫瘤的可行性。

61 、A final analysis was carried out for the 81 patients with glioblastoma (median age, 73 years;───最終分析了膠質(zhì)母細胞瘤81例(年齡70歲--85歲、平均73歲)。

62 、Human glioblastoma───人腦星型膠質(zhì)母細胞瘤

63 、one example is temozolomide, which is the only chemotherapy available for treating brain tumours such as glioblastoma multiforme and progressive anaplastic astrocytoma.───一個(gè)例子是替莫唑胺，這是目前唯一用于治療腦腫瘤，如多形性惡性膠質(zhì)瘤和進(jìn)展性多形性成膠質(zhì)細胞瘤的化療藥物。

64 、It accounts for 40%-45% of all human primary brain tumors.Because of high vascularity, glioblastoma multiforme can be used as an ideal model for angiogenesis and anti-angiogenesis study.───由于其特異性的高度血管化,多型性膠質(zhì)母細胞瘤可作為研究腫瘤血管化生成過(guò)程和抗血管化治療的理想模型。

65 、Glioblastoma muhiforme───多形性膠質(zhì)母細胞瘤

66 、Background There is no community standard for the treatment of glioblastoma in patients 70 years of age or older.───背景：對于70歲以上（含70歲）的老年惡性膠質(zhì)瘤患者的治療尚無(wú)公認的標準。

67 、The other two studies are looking at the effect of measles on recurrent oarian cancer and a type of brain tumor called glioblastoma multiforme.───另兩項試驗用于測試麻疹病毒治療復發(fā)卵巢癌和一種腦腫瘤多形性膠質(zhì)母細胞瘤。

68 、multiform glioblastoma───多形性成膠質(zhì)細胞瘤, 多形性惡性膠質(zhì)瘤

69 、“MGMT silencing is currently being used as a prognostic indicator of successful alkylation chemotherapy for glioblastoma;───他們寫(xiě)到：“目前使用MGMT沉默現象來(lái)作為預測烷基化化療治療膠質(zhì)母細胞瘤預后效果的指標；

70 、Glioblastoma multiforme (GBM) is the most common and lethal type of brain cancer.───多形性膠質(zhì)母細胞瘤(GBM)是最常見(jiàn)的致命性的腦部腫瘤。

71 、The endogenous regulation of self-renewal in human glioblastoma stem cells───人膠質(zhì)瘤干細胞內在自我更新能力

72 、Next, the scientists deliered slow-release BMP4-containing "beads" directly into mouse brains with implanted glioblastoma cells.───其次，給小鼠植入膠質(zhì)瘤細胞后，科學(xué)家再將一種可以緩慢釋放BMP4的珠狀物直接注入小鼠腦細胞中。

73 、Every patient is different, of course, and you should know we have no data on this application with a glioblastoma like yours.─── 當然 每個(gè)病人都不一樣 你要知道 對于像你這樣的膠質(zhì)母細胞瘤 我們沒(méi)有這方面的應用數據

74 、In the past few years the government has spent $100 million dollars for genome studies in lung and ovarian cancers and glioblastoma multiforme, a type of brain tumor.───在過(guò)去的幾年中，政府為肺癌、卵巢癌、腦膠質(zhì)母細胞瘤（一種腦組織腫瘤）的基因組研究上投入了1億美元。

75 、MRI and ultrasound technique have improved the diagnosis of glioblastoma and increased clinical value for themselves.───摘要MRI與超聲技術(shù)在膠質(zhì)細胞瘤的診斷中不斷改進(jìn)，增強了臨床診斷價(jià)值。

76 、Mechanisms of drug effect and recurrence of glioblastoma should be put in more emphasis for research work.───有待加強對藥物作用機制、腫瘤復發(fā)機制方面的研究。

77 、recurring glioblastoma───復發(fā)腦膠質(zhì)母細胞瘤

78 、The prognosis for patients with glioblastoma multiforme (GBM), the most common primary brain tumor, is dismal.───多形性膠質(zhì)母細胞瘤(GBM)是常見(jiàn)的原發(fā)性腦腫瘤，患者的預后不佳。

79 、Methods A case of glioblastoma contained foci epithelial differentiation (adenoid glioblastoma) was analyzed with HE and immunohistochemical stains and review of the literature.───方法采用HE染色、免疫組化對1例術(shù)后病理證實(shí)為腺樣膠質(zhì)母細胞瘤的病例進(jìn)行詳細的觀(guān)察。

80 、Keywords loss of heterozygosity;glioblastoma;genes;suppress or;tumor;───雜合性丟失;膠質(zhì)母細胞瘤;基因;抑制;腫瘤;

81 、Most middle-aged, anaplastic astrocytoma showed the peak incidence at 50 years of age, while the glioblastoma multiforme tumor incidence peaks about 10 years later.───中年人最多，間變性星形膠質(zhì)細胞瘤發(fā)病在50歲呈高峰，而多形性膠質(zhì)母細胞瘤發(fā)病高峰晚10年左右。

82 、It will make her glioblastoma respond better to her clinical trial.─── 這會(huì )讓她的膠質(zhì)母細胞瘤 對臨床試驗起更好的反應

83 、Glioblastoma multiforme (GBM) is the most common glioma (a type of brain cancer).───最常見(jiàn)的膠質(zhì)瘤，大約占原發(fā)性腦腫瘤的1/4。

84 、SEGA is a benign,slowly growing and possible multidifferentiated tumor,and it should be differentiated from giant cell glioblastoma,gemistocytic astrocytoma and ependymoma.───SEGA為生長(cháng)緩慢的良性腫瘤,生存時(shí)間長(cháng),預后良好,可能具有多向分化潛能,病理確診須與巨細胞性膠質(zhì)母細胞瘤、肥胖細胞性星形細胞瘤和室管膜瘤等鑒別。

85 、Conclusion Postoperative radiotherapy plus concomitant adjuvant chemotherapy for glioblastoma seems to be beneficial with minimal additional toxicity.───結論術(shù)后同步放化療對腦惡性膠質(zhì)瘤患者具有潛在的治療價(jià)值,并很少增加毒性反應。

86 、In addition, the drug resulted in a significant, 27% increase of survival of mice with glioblastoma tumours and a shrinking of glioblastoma tumours in rats.───此外，該藥物使惡性膠質(zhì)瘤小鼠的生存率增加了27 %，使大鼠惡性膠質(zhì)瘤體積縮小。

87 、If this is a primary brain tumor, possibilities include medulloblastoma (rare, but does occur in older individuals) and small cell variant of glioblastoma.───如果這是原發(fā)于腦的腫瘤，可能的診斷是髓母細胞瘤（罕見(jiàn)，但確實(shí)可以在老年人中出現）和膠質(zhì)母細胞瘤的小細胞變異型。

88 、Grade IV gliomas (glioblastoma multiforme).Surgery is required to establish tissue diagnosis and debulk the lesion.───WHO四級膠質(zhì)瘤（多形性膠質(zhì)母細胞瘤）：同樣需要手術(shù)來(lái)達到組織病理診斷和減小腫瘤體積。

抗瘧疾藥物本芴醇是如何抑制膠質(zhì)母細胞瘤的？

作為一種相當致命的腦癌，膠質(zhì)母細胞瘤（glioblastoma）患者的五年生存率一直非常低（不到 6%）。

好消息是，弗吉尼亞聯(lián)邦大學(xué)的科學(xué)家們，剛剛為傳統抗瘧疾藥物找到了新的應用場(chǎng)景。

結合有限的放療和替莫唑胺（Temoside）化療，小鼠實(shí)驗已表明了抗瘧疾藥物的有效性。

Paul B. Fisher，來(lái)自：Virginia Commonwealth University

通常情況下，膠質(zhì)母細胞瘤會(huì )表現出對這些標準護理方式的抗性，導致惡性腫瘤繼續在大腦中**。

不過(guò)新研究發(fā)現，本芴醇效果取決于被稱(chēng)作 Fli-1 的遺傳因子在應對膠質(zhì)母細胞瘤治療抗性的新認知。

其能夠調節膠質(zhì)母細胞瘤中 aa 突體蛋白的表達（即“熱休克蛋白”HSPB1），為干預和限制惡性腫瘤的生長(cháng)開(kāi)辟了新的可能。

弗吉尼亞聯(lián)邦大學(xué)團隊借助先進(jìn)的篩選技術(shù)來(lái)尋找可抑制 Fli-1 的藥物，結果發(fā)現當前已獲批準的抗瘧疾藥物本芴醇（lumefantrine）具有這種獨特的能力。

據悉，本芴醇可以與 Fli-1 結合并使之失活，從而終止驅動(dòng)腫瘤形成的基因的表達。有鑒于此，研究團隊決定通過(guò)一些實(shí)驗測試來(lái)證明。

在早期體外研究中，膠質(zhì)母細胞瘤細胞會(huì )在放療和化療的情況下繼續生長(cháng)。但在摻入本芴醇之后，便可有效殺死癌細胞并抑制腫瘤的生長(cháng)。

在第二輪小鼠研究中，研究團隊再次發(fā)現它能夠抑制腫瘤細胞的生長(cháng)，即便是那些曾經(jīng)對放化療表現出抗性的癌細胞。

除了靶向 HSPB1，該團隊的工作還表明，該藥物對另外兩種機制也產(chǎn)生了影響 —— 細胞外基質(zhì)（ECM）重塑和上皮間質(zhì)的轉化，也受 Fli-1 的調節和被該藥物抑制。

首席研究員 Paul B. Fisher 表示，這些臨床前研究為膠質(zhì)母細胞瘤的 Fli-1 / HSPB1 抑制提供了堅實(shí)的依據，有助于推動(dòng)治療腦癌等疾病的新方法。

有關(guān)這項研究的詳情，已經(jīng)發(fā)表在近日出版的《美國國家科學(xué)院院刊》（PNAS）上。

原標題為《Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma》。

什么是細胞瘤

病情分析：細胞瘤也就是造釉細胞瘤是一種比較常見(jiàn)的、來(lái)自牙源性上皮的頜骨中心性腫瘤。瘤細胞的形態(tài)與牙胚中的造釉細胞相似，故稱(chēng)為造釉細胞瘤。發(fā)病人群造釉細胞瘤多見(jiàn)于青壯年。 細胞瘤也就是造釉細胞瘤是一種比較常見(jiàn)的、來(lái)自牙源性上皮的頜骨中心性腫瘤。瘤細胞的形態(tài)與牙胚中的造釉細胞相似，故稱(chēng)為造釉細胞瘤。發(fā)病人群造釉細胞瘤多見(jiàn)于青壯年。 腎母細胞瘤，它屬于是一種胚胎性的惡性一個(gè)腫瘤，多半認為源于腎胚基細胞。腎母細胞瘤好發(fā)于兒童，是兒童第二位常見(jiàn)的腹部惡性腫瘤，98%的病例發(fā)生于10歲以下，最多見(jiàn)于3歲以下的兒童。